Literature DB >> 15556632

Structural determinants of the selectivity of KTS-disintegrins for the alpha1beta1 integrin.

Dariusz G Kisiel1, Juan J Calvete, Jehoshua Katzhendler, Andrzej Fertala, Philip Lazarovici, Cezary Marcinkiewicz.   

Abstract

KTS-disintegrins are a subfamily of short monomeric disintegrins that are potent and selective inhibitors of alpha1beta1 integrin. The amino acid sequence of the new KTS-disintegrin, viperistatin, differs from previously characterized obtustatin in three residues at position 24 (within the integrin binding loop), 38 (hydrophobic core) and 40 (C-terminal region). Noteworthy, viperistatin is about 25-fold more potent than obtustatin inhibiting the binding of this integrin to collagen IV. Synthetic peptides representing the full-length of integrin-binding loops of these disintegrins showed that the Leu24/Arg substitution appears to be partly responsible for the increased inhibitory activity of viperistatin over obtustatin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15556632     DOI: 10.1016/j.febslet.2004.10.050

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Molecular cloning of disintegrins from Cerastes vipera and Macrovipera lebetina transmediterranea venom gland cDNA libraries: insight into the evolution of the snake venom integrin-inhibition system.

Authors:  Libia Sanz; Amine Bazaa; Naziha Marrakchi; Alicia Pérez; Mehdi Chenik; Zakaria Bel Lasfer; Mohamed El Ayeb; Juan J Calvete
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

Review 2.  Applications of snake venom components to modulate integrin activities in cell-matrix interactions.

Authors:  Cezary Marcinkiewicz
Journal:  Int J Biochem Cell Biol       Date:  2013-06-26       Impact factor: 5.085

3.  The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse model.

Authors:  Narine Ghazaryan; Naira Movsisyan; Joana Catarina Macedo; Sara Vaz; Naira Ayvazyan; Luis Pardo; Elsa Logarinho
Journal:  Invest New Drugs       Date:  2019-01-25       Impact factor: 3.850

4.  Angiostatic activity of obtustatin as alpha1beta1 integrin inhibitor in experimental melanoma growth.

Authors:  Meghan C Brown; Izabela Staniszewska; Luis Del Valle; George P Tuszynski; Cezary Marcinkiewicz
Journal:  Int J Cancer       Date:  2008-11-01       Impact factor: 7.396

Review 5.  Snake venom disintegrins and cell migration.

Authors:  Heloisa S Selistre-de-Araujo; Carmen L S Pontes; Cyntia F Montenegro; Ana Carolina B M Martin
Journal:  Toxins (Basel)       Date:  2010-10-29       Impact factor: 4.546

Review 6.  Pharmacological aspects of Vipera xantina palestinae venom.

Authors:  Tatjana Momic; Franziska T Arlinghaus; Hadar Arien-Zakay; Jeoshua Katzhendler; Johannes A Eble; Cezary Marcinkiewicz; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2011-11-14       Impact factor: 4.546

Review 7.  Disintegrins from snake venoms and their applications in cancer research and therapy.

Authors:  Jéssica Kele Arruda Macêdo; Jay W Fox; Mariana de Souza Castro
Journal:  Curr Protein Pept Sci       Date:  2015       Impact factor: 3.272

8.  Neuronal conditioning medium and nerve growth factor induce neuronal differentiation of collagen-adherent progenitors derived from human umbilical cord blood.

Authors:  Hadar Arien-Zakay; Arnon Nagler; Hanan Galski; Philip Lazarovici
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 2.866

Review 9.  Metalloproteases Affecting Blood Coagulation, Fibrinolysis and Platelet Aggregation from Snake Venoms: Definition and Nomenclature of Interaction Sites.

Authors:  R Manjunatha Kini; Cho Yeow Koh
Journal:  Toxins (Basel)       Date:  2016-09-29       Impact factor: 4.546

10.  Ndr2 Kinase Controls Neurite Outgrowth and Dendritic Branching Through α1 Integrin Expression.

Authors:  Yunus E Demiray; Kati Rehberg; Stefanie Kliche; Oliver Stork
Journal:  Front Mol Neurosci       Date:  2018-03-06       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.